It is tempting to speculate that a similar mechanism may operate in renal cancer whereby the production of interleukin-1 by tumor-infiltrating monocytes may not only stimulate RCC cells to sustain an inflammatory microenvironment but also induce epithelial memory impacting on tumor progression through IL6 production. Here, IL6 is linked to renal carcinoma.